Rocket Pharmaceuticals, Inc. Dilutive Share Adjustment
Rocket Pharmaceuticals, Inc. (RCKT) reported Dilutive Share Adjustment of 1.67 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2026-08-10
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2026-06-30 was 1.67M shares.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2026-03-31 was 23.83M shares, a 0.32% decline year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2025-12-31 was 4.06M shares, a 78.87% decline year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2025-09-30 was 24.16M shares, a 18.30% increase year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for fiscal 2025 was 19.13M shares, a 4.88% decline from fiscal 2024.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for fiscal 2024 was 20.12M shares, a 6.20% increase from fiscal 2023.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for fiscal 2023 was 18.94M shares, a 12.40% increase from fiscal 2022.
- Rocket Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for fiscal 2022 was 16.85M shares, a 36.07% increase from fiscal 2021.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month as first filed | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month as first filed | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month as first filed | Weighted Average Number Diluted Shares Outstanding Adjustment 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.67M shares 10-Q · filed 2026-08-10 | 1.84M shares 10-Q · filed 2026-08-10 | 9.85M shares derived: average of 3 quarters · filed 2026-08-10 | 13.43M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | 23.83M shares 10-Q · filed 2026-05-07 | 13.94M shares derived: average of 2 quarters · filed 2026-05-07 | 17.35M shares derived: average of 3 quarters · filed 2026-05-07 | 13.01M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | 4.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 14.11M shares derived: average of 2 quarters · filed 2026-02-26 | 9.41M shares derived: average of 3 quarters · filed 2026-08-10 | 19.13M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 24.16M shares 10-Q · filed 2025-11-06 | 12.08M shares derived: average of 2 quarters · filed 2026-08-10 | 24.16M shares 10-Q · filed 2025-11-06 | 16.82M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-10 | 22.75M shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2026-08-10 | 22.75M shares 10-Q · filed 2025-08-07 | 14.37M shares derived: average of 3 quarters · filed 2026-08-10 | 15.88M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | 23.91M shares 10-Q · filed 2026-05-07 | 21.55M shares derived: average of 2 quarters · filed 2026-05-07 | 21.18M shares derived: average of 3 quarters · filed 2026-05-07 | 21.02M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 19.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 19.81M shares derived: average of 2 quarters · filed 2026-02-26 | 20.05M shares derived: average of 3 quarters · filed 2026-02-26 | 20.12M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 20.42M shares 10-Q · filed 2025-11-06 | 20.48M shares derived: average of 2 quarters · filed 2025-11-06 | 20.42M shares 10-Q · filed 2025-11-06 | 19.97M shares derived: average of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | 20.54M shares 10-Q · filed 2025-08-07 | 20.54M shares 10-Q · filed 2025-08-07 | 19.82M shares derived: average of 3 quarters · filed 2025-08-07 | 19.63M shares derived: average of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | 20.39M shares 10-Q · filed 2025-05-08 | 19.46M shares derived: average of 2 quarters · filed 2025-05-08 | 19.33M shares derived: average of 3 quarters · filed 2025-05-08 | 19.28M shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 18.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 18.80M shares derived: average of 2 quarters · filed 2025-02-27 | 18.91M shares derived: average of 3 quarters · filed 2025-02-27 | 18.94M shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 19.08M shares 10-Q · filed 2024-11-07 | 19.10M shares derived: average of 2 quarters · filed 2024-11-07 | 19.08M shares 10-Q · filed 2024-11-07 | 19.99M shares derived: average of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | 19.12M shares 10-Q · filed 2023-08-09 | 19.12M shares 10-Q · filed 2024-08-06 | 20.29M shares derived: average of 3 quarters · filed 2025-02-27 | 18.93M shares derived: average of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | 18.87M shares 10-Q · filed 2024-05-07 | 20.87M shares derived: average of 2 quarters · filed 2025-02-27 | 18.86M shares derived: average of 3 quarters · filed 2025-02-27 | 17.72M shares derived: average of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | 22.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 18.86M shares derived: average of 2 quarters · filed 2025-02-27 | 17.33M shares derived: average of 3 quarters · filed 2025-02-27 | 16.85M shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 14.84M shares 10-Q · filed 2023-11-07 | 14.56M shares derived: average of 2 quarters · filed 2023-11-07 | 14.84M shares 10-Q · filed 2023-11-07 | 14.22M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | 14.27M shares 10-Q · filed 2023-08-09 | 14.27M shares 10-Q · filed 2023-08-09 | 14.01M shares derived: average of 3 quarters · filed 2024-02-27 | 13.47M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | 13.72M shares 10-Q · filed 2023-05-05 | 13.88M shares derived: average of 2 quarters · filed 2024-02-27 | 13.20M shares derived: average of 3 quarters · filed 2024-02-27 | 12.86M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | 14.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 12.94M shares derived: average of 2 quarters · filed 2024-02-27 | 12.57M shares derived: average of 3 quarters · filed 2024-02-27 | 12.39M shares 10-K · filed 2024-02-27 | |||
| 2021-09-30 | 11.84M shares 10-Q · filed 2022-11-04 | 12.04M shares 10-Q · filed 2021-11-05 | 11.84M shares derived: average of 2 quarters · filed 2022-11-04 | 11.84M shares 10-Q · filed 2022-11-04 | 12.04M shares 10-Q · filed 2021-11-05 | 12.73M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | 11.84M shares 10-Q · filed 2022-08-09 | 11.84M shares 10-Q · filed 2022-08-09 | 13.03M shares derived: average of 3 quarters · filed 2023-02-28 | 12.91M shares derived: average of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | 12.86M shares 10-Q · filed 2022-05-06 | 13.63M shares derived: average of 2 quarters · filed 2023-02-28 | 13.27M shares derived: average of 3 quarters · filed 2023-02-28 | 13.06M shares derived: average of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | 14.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 13.48M shares derived: average of 2 quarters · filed 2023-02-28 | 13.12M shares derived: average of 3 quarters · filed 2023-02-28 | 13.02M shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 12.56M shares 10-Q · filed 2021-11-05 | 12.48M shares derived: average of 2 quarters · filed 2021-11-05 | 12.56M shares 10-Q · filed 2021-11-05 | ||||
| 2020-06-30 | 12.41M shares 10-Q · filed 2021-08-09 | 12.41M shares 10-Q · filed 2021-08-09 | |||||
| 2020-03-31 | 12.17M shares 10-Q · filed 2021-05-10 | ||||||
| 2019-12-31 | 11.24M shares 10-K · filed 2022-02-28 | ||||||
| 2018-12-31 | 10.25M shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |